Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake

Journal of Hypertension

Volumn 22, Issue 2, 2004, Pages 287-295

  Kuznetsova, Tatiana ^a,b   Staessen, Jan A ^a   Stolarz, Katarzyna ^c   Ryabikov, Andrew ^d   Tikhonoff, Valérie ^d   Olszanecka, Agnieszka ^c   Bianchi, Giuseppe ^e   Brand, Eva ^f,g   Casiglia, Edoardo ^d   Dominiczak, Anna ^h   Fagard, Robert ^a   Malyutina, Sofia ^b   Nikitin, Yuri ^b   Kawecka Jaszcz, Kalina ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Institute of Internal and Preventive Medicine   (Russian Federation)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY OF PADOVA   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f HUMBOLDT UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h WESTERN INFIRMARY   (United Kingdom)

Author keywords

Aldosterone; Angiotensin converting enzyme; Genes; Left ventricular mass; Polymorphism; Sodium

Indexed keywords

ALDOSTERONE SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM;

ADULT; ALLELE; ARTICLE; BODY SURFACE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART LEFT VENTRICLE VOLUME; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROGENY; SODIUM INTAKE; SODIUM URINE LEVEL;

EID: 10744223178     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200402000-00012     Document Type: Article

References (35)

1. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham heart study. Ann Intern Med 1988; 108:7-13.
2. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141:334-341.
3. Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP. Association of echocardiographic left ventricular mass with body size, blood pressure, and physical activity (the Framingham Study). Am J Cardiol 1990; 65:371-376.
4. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993; 87:476-486.
5. Schmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-1309.
6. Du Cailar G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002; 15:222-229.
7. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153:937-942.
8. Campbell DJ. Tissue renin-angiotensin system: sites of angiotensin formation. J Cardiovasc Pharmacol 1987; 10(suppl 7):S1-S8.
9. Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsky J, et al, on behalf of the EPOGH Investigators. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7:215-224.
10. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhäger WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19:1349-1358.
11. Forty-first World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24:606-609.
12. Petrie JC, O'Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement by a working party of the British Hypertension Society. BMJ 1989; 293:611-615.
13. Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens 1988; 6:965-973.
14. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for the angiotensin converting enzyme. Anal Biochem 1979; 95:540-548.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
17. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986; 1:307-310
18. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332:706-711.
19. Brand E, Chatelain N, Mulatero P, Féry I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32:198-204.
20. The SAS Institute. The GENMOD procedure. SAS Online Doc Version 7.1: SAS/STAT. Cary, North Carolina, USA: The SAS Institute Inc.; 2000, pp. 1311-1411.
21. Abecasis GR, Cardon LR, Cookson WOC. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66:279-292.
22. Abecasis GR, Cookson WOC, Cardon LR. Pedigree tests of transmission disequilibrium. Eur J Hum Genet 2000; 8:545-551.
23. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, Julier C, et al. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 2001; 10:1077-1084.
24. Allison DB. Transmission-disequilibrium test for quantitative traits. Am J Hum Genet 1997; 60:676-690.
25. Waldman ID, Robinson BF, Rowe DC. A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 1999; 63:329-340.
26. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002; 296:695-698.
27. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12:2053-2133.
28. van der Kleij FGH, de Jong PE, Henning RH, de Zeeuw D, Navis G. Enhanced responses of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. J Am Soc Nephrol 2002; 13:1025-1033.
29. Cole JM, Khokhlova N, Sutliff RL, Adams JW, Disher KM, Zhao H, et al. Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II. Hypertension 2003; 41:313-321.
30. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 1993; 11(suppl):S13-S18.
31. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, et al. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996; 27:569-572.
32. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de la Sierra A. Molecular basis for salt sensitivity in human hypertension. Evaluation of the renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38:1204-1209.
33. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin angiotensin aldosterone system. Circulation 1991; 83:1849-1865.
34. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34: 423-429.
35. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4:805-808.